Interleukin-23 inhibitor outperforms Johnson & Johnson's blockbuster
Moving to a more coordinated and cooperative European response to health threats
The convergence of food and pharmaceuticals is set to create a huge growth market
New medical information website aims to be a 'simple, centralised repository'
AnnKatrin Petersen-Jappelli to strengthen company
Obsolete business models are making space for the new
Samer Kaba joins the firm
Marks the first non-English capability for the US company
Communications director Andy Powrie-Smith on why the Code is part of pharma's 'licence to operate'
Janssen's Cyril Titeux on responding to the industry's pricing, access and reputational challenges